Your browser doesn't support javascript.
loading
A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma.
Ghosh, Subhajit; Johanns, Tanner M; Chheda, Milan G; Liu, Eric; Butt, Omar; Abraham, Christopher; Badiyan, Shahed; Huang, Yi; DeNardo, David; Kim, Albert H; Hallahan, Dennis; Thotala, Dinesh; Huang, Jiayi.
Afiliación
  • Ghosh S; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Johanns TM; Department of Radiation Oncology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Chheda MG; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Liu E; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Butt O; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Abraham C; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Badiyan S; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Huang Y; Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • DeNardo D; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Kim AH; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Hallahan D; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Thotala D; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Huang J; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.
Neurooncol Adv ; 5(1): vdad088, 2023.
Article en En | MEDLINE | ID: mdl-37554225
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos